Veranova Expands Advisory Board with Appointment of Dr. Marvin H. Caruthers

April 23, 2025

Devens, MA, USA — Veranova, a global leader in the development and manufacturing of specialty and complex active pharmaceutical ingredients (APIs) for the pharmaceutical and biotech sectors, is proud to announce the appointment of Dr. Marvin (Marv) Caruthers, to its Advisory Board.

Dr. Caruthers brings a lifetime of scientific excellence and biotechnological innovation to Veranova. A distinguished biochemist and pioneer in nucleic acid chemistry, Dr. Caruthers’ groundbreaking research laid the foundation for modern DNA and RNA synthesis techniques. His contributions to the phosphoramidite method revolutionized oligonucleotide synthesis and remain central to genomic research and therapeutics today.

“Dr. Caruthers’ remarkable career at the forefront of chemical biology, combined with his track record of founding and guiding transformative companies, will be invaluable as Veranova continues to expand our innovation-driven service offerings,” said Mike Riley, CEO of Veranova. “We are honored to welcome him to our Advisory Board.”

Dr. Caruthers earned his B.S. in Chemistry from Iowa State University in 1962 and his Ph.D. in Biochemistry from Northwestern University in 1968 under the mentorship of Robert Letsinger. He pursued postdoctoral research with Nobel Laureate Har Gobind Khorana at the Massachusetts Institute of Technology before joining the University of Colorado Boulder in 1973, where he currently serves as a Distinguished Professor of Biochemistry.

Throughout his career, Dr. Caruthers has been recognized with numerous prestigious honors, including election to the National Academy of Sciences and the American Academy of Arts and Sciences in 1994. He is the recipient of the National Medal of Science (2006), the NAS Award for Chemistry in Service to Society (2005), and the NAS Award in Chemical Sciences (2014). In addition to his academic achievements, Dr. Caruthers co-founded two landmark biotechnology companies – Amgen and Applied Biosystems – both of which have played pivotal roles in the advancement of the life sciences industry.

Dr. Caruthers will join current advisory board members Dr. Rajni Aneja, Dr. Carolyn Bertozzi, Carlo de Notaristefani, Dr. Bradley Pentelute, John Nason and Edward Robinson.

 

About Veranova

Veranova is a global leader in process development and manufacturing of APIs, with a focus on specialty and complex chemistry for small molecules, antibody-drug conjugates, oligonucleotides and peptides. Veranova is headquartered in Devens, Massachusetts and has operations in North America and Europe.

 

Contact Details

For further information and interview opportunities with Veranova, please contact:
Charles Ben-Cofie
Senior Content Manager, Notch Communications
T: +44 (0) 161 457 7230
E: charles.ben-cofie@notchcommunications.co.uk